Abstract
Cardiac health depends on the heart’s ability to utilize different substrates to support overall oxidative metabolism. To characterize a variety of cardiac diseases, there is an ever-growing demand for an accurate non-invasive approach to evaluating myocardial substrate metabolism. Data obtained from quantitative metabolic imaging modalities add functional information to the anatomic imaging modalities and can aid patient management.
The goal of this review is to emphasize the role of non-invasive imaging techniques (such as PET, SPECT, MR spectroscopy and spectroscopic imaging) to detect the metabolic footprints of heart disease. The advancements of models and methods to estimate kinetic parameters of dynamic processes using data acquired from cardiac imaging modalities is discussed.
Keywords: Positron emission tomography, single photon emission computed tomography, magnetic resonance spectroscopy, magnetic resonance spectroscopic imaging, cardiac metabolism, metabolic imaging, compartmental models, kinetic models, kinetic parameter estimation and fitting.
Current Pharmaceutical Design
Title:Models and Methods in Cardiac Imaging for Metabolism Studies
Volume: 20 Issue: 39
Author(s): Santarelli M.F., Martini N., Positano P. and Landini L.
Affiliation:
Keywords: Positron emission tomography, single photon emission computed tomography, magnetic resonance spectroscopy, magnetic resonance spectroscopic imaging, cardiac metabolism, metabolic imaging, compartmental models, kinetic models, kinetic parameter estimation and fitting.
Abstract: Cardiac health depends on the heart’s ability to utilize different substrates to support overall oxidative metabolism. To characterize a variety of cardiac diseases, there is an ever-growing demand for an accurate non-invasive approach to evaluating myocardial substrate metabolism. Data obtained from quantitative metabolic imaging modalities add functional information to the anatomic imaging modalities and can aid patient management.
The goal of this review is to emphasize the role of non-invasive imaging techniques (such as PET, SPECT, MR spectroscopy and spectroscopic imaging) to detect the metabolic footprints of heart disease. The advancements of models and methods to estimate kinetic parameters of dynamic processes using data acquired from cardiac imaging modalities is discussed.
Export Options
About this article
Cite this article as:
M.F. Santarelli, N. Martini, P. Positano and L. Landini, Models and Methods in Cardiac Imaging for Metabolism Studies, Current Pharmaceutical Design 2014; 20 (39) . https://dx.doi.org/10.2174/1381612820666140417114122
DOI https://dx.doi.org/10.2174/1381612820666140417114122 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Reversal of Cardiac Iron Loading and Dysfunction in Thalassemic Mice by Curcuminoids
Medicinal Chemistry Role of Pancreatic β-Cell Death and Cell Death-Associated Inflammation in Diabetes
Current Molecular Medicine Endothelial Dysfunction in the Hypertensive State: Mechanisms of Hypertensive Cardiovascular Complications
Current Hypertension Reviews Mast Cells and Inflammatory Heart Disease: Potential Drug Targets
Cardiovascular & Hematological Disorders-Drug Targets Targeting Na/K-ATPase Signaling: A New Approach to Control Oxidative Stress
Current Pharmaceutical Design Infective Endocarditis Complicating Hypertrophic Obstructive Cardiomyopathy: Is Antibiotic Prophylaxis Really Unnecessary?
Current Cardiology Reviews The Emerging Roles of Leptin and Ghrelin in Cardiovascular Physiology and Pathophysiology
Current Vascular Pharmacology Umbilical Cord Tissue Mesenchymal Stem Cells: Characterization and Clinical Applications
Current Stem Cell Research & Therapy Stem Cells as In Vitro Models of Disease
Current Stem Cell Research & Therapy Drug-Related Cardiotoxicity for the Treatment of Haematological Malignancies in Elderly
Current Pharmaceutical Design Acute Coronary Syndromes in Patients with Atrial Fibrillation and Heart Failure. Could Novel Oral Anticoagulants be the Solution of the Optimal Antithrombotic Therapy Puzzle?
Cardiovascular & Hematological Agents in Medicinal Chemistry Diagnosis and Management of Heart Failure with Preserved Ejection Fraction: 10 Key Lessons
Current Cardiology Reviews The Zebrafish as a Novel Tool for Cardiovascular Drug Discovery
Recent Patents on Cardiovascular Drug Discovery Pharmacological Approaches of Binge Drinking
Current Pharmaceutical Design Mitochondria Damage in the Pathogenesis of Diabetic Retinopathy and in the Metabolic Memory Associated with its Continued Progression
Current Medicinal Chemistry Left Ventricular Hypertrophy in Isolated Aortic Stenosis: Primetime for the Ventricle
Current Pharmaceutical Biotechnology Gluten-dependent Intestinal Autoimmune Response
Current Pharmaceutical Design New Antihypertensive Drugs Under Development
Current Medicinal Chemistry New Genetic Polymorphisms as an Epidemiological Factor of Arterial Hypertension in Patients with Hyposodical Diet
Current Hypertension Reviews Nitroso-Redox Balance and Modulation of Basal Myocardial Function: An Update from the Italian Society of Cardiovascular Research (SIRC)
Current Drug Targets